Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Product › Details

Agrippal®

	Next higher product group	vaccine, influenza_o
	Status	1999-07-30 registration start
	Organisation	Chiron (Group)
	Today	Chiron (business unit of Novartis Vaccines and Diagnostics Inc.)
	Group	Novartis (Group)

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for vaccine, influenza

[1] BiondVax Pharmaceuticals Ltd.. (1/28/21). "Press Release: BiondVax Announces Third Quarter 2020 Financial Results & Business Update". Jerusalem....
[2] BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem....
[3] BiondVax Pharmaceuticals Ltd.. (10/23/20). "Press Release: BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate". Jerusalem....
[4] Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford....
[5] BioNTech AG. (8/16/18). "Press Release: BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". Mainz & New York, NY....
[6] BiondVax Pharmaceuticals Ltd.. (4/30/18). "Press Release: BiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and Update". Ness Ziona....
[7] BiondVax Pharmaceuticals Ltd.. (4/11/18). "Press Release: BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of its Universal Flu Vaccine in the United States". Ness Ziona....
[8] BiondVax Pharmaceuticals Ltd.. (12/5/17). "Press Release: BiondVax’s CEO Issues Letter to Shareholders". Ness Ziona....
[9] BiondVax Pharmaceuticals Ltd.. (9/18/17). "Press Release: BiondVax Announces Closing of $10 Million Public Offering of American Depositary Shares and Exercise of Over-Allotment Option". Ness Ziona....
[10] BiondVax Pharmaceuticals Ltd.. (9/14/17). "Press Release: BiondVax Announces Pricing of Public Offering of American Depositary Shares". Ness Ziona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]